Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, suppresses the progression of atherosclerosis in diabetic apoE-deficient mice. (October 2016) - Murakami, Saiko; Matsumura, Takeshi; Senokuchi, Takafumi; Ishii, Norio; Fukuda, Kazuki; Yamada, Sarie; Morita, Yutaro; Nishida, Shuhei; Sato, Miki; Motoshima, Hiroyuki; Kondo, Tatsuya; Araki, Eiichi